When will we see the new male contraceptive since the condom? | Diana Blithe | Nobel Conference
Diana Blithe, PhD presenting “Prospects and Pipeline for Male Contraception” at the 53rd annual Nobel Conference at Gustavus Adolphus College in 2017.
Dr. Blithe reports on the current state of research on male contraceptives, funding structures, and United States governmental oversight.
Blithe is the program director for the Male Contraceptive Development Program at the National Institutes of Health. As the co-director of the Contraceptive Clinical Trials Network, she oversees clinical trials to evaluate the safety and efficacy of new contraceptive agents for men and women. Blithe’s work as a program director has given her a perspective on crucial questions about why and how particular contraceptive research gets funded. Blithe’s scientific expertise includes biochemistry, endocrinology, and glycobiology.
#reproduction
#contraception
#nobelconference
#scienceandethics
#citizenscience
#science
The Nobel Conference: Science and Ethics, in Dialogue
Since 1965, the Nobel Conference has been bringing leading researchers and thinkers to Gustavus Adolphus College in Saint Peter, Minnesota, to explore revolutionary, transformative and pressing scientific issues and the ethical questions that arise alongside them.
As the only event in the United States authorized by the Nobel Foundation in Stockholm, Sweden to use this name, it is our privilege to host a space in which we can talk about big scientific questions, and the big ethical issues to which they inevitably give rise. The world needs more people who think critically about the crucial issues of our time, and who ask questions in ways that open up the conversation.
Find us at https://gustavus.edu/nobelconference
Follow us on Facebook at https://www.facebook.com/NobelConference
Follow us on Twitter at https://twitter.com/NobelConference
